XML 72 R7.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Aug. 29, 2019
Aug. 30, 2018
Aug. 31, 2017
Cash flows from operating activities      
Net income $ 6,358 $ 14,138 $ 5,090
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation expense and amortization of intangible assets 5,424 4,759 3,861
Amortization of debt discount and other costs 49 101 125
Loss on debt prepayments, repurchases, and conversions 396 385 99
Stock-based compensation 243 198 215
Gain on remeasurement of previously-held equity interest in Inotera 0 0 (71)
Change in operating assets and liabilities      
Receivables 2,431 (1,734) (1,651)
Inventories (1,528) (472) 50
Accounts payable and accrued expenses (174) 668 456
Payments attributed to intercompany balances with Inotera 0 0 (361)
Deferred income taxes, net 150 (265) (22)
Other (160) (378) 362
Net cash provided by operating activities 13,189 17,400 8,153
Cash flows from investing activities      
Expenditures for property, plant, and equipment (9,780) (8,879) (4,734)
Purchases of available-for-sale securities (4,218) (760) (1,239)
Acquisition of Inotera 0 0 (2,634)
Proceeds from maturities of available-for-sale securities 1,541 320 194
Proceeds from sales of available-for-sale securities 1,504 604 776
Proceeds from government incentives 748 355 21
Other 120 144 79
Net cash provided by (used for) investing activities (10,085) (8,216) (7,537)
Cash flows from financing activities      
Repayments of debt (3,340) (10,194) (2,558)
Payments to acquire treasury stock (2,729) (71) (36)
Payments on equipment purchase contracts (75) (206) (519)
Proceeds from issuance of debt 3,550 1,009 3,311
Proceeds from issuance of stock 179 1,655 142
Other (23) 31 9
Net cash provided by (used for) financing activities (2,438) (7,776) 349
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash 26 (37) (12)
Net increase in cash, cash equivalents, and restricted cash 692 1,371 953
Cash, cash equivalents, and restricted cash at beginning of period 6,587 5,216 4,263
Cash, cash equivalents, and restricted cash at end of period 7,279 6,587 5,216
Supplemental disclosures      
Income taxes paid, net (524) (226) (99)
Interest paid, net of amounts capitalized (53) (312) (468)
Noncash investing and financing activity      
Equipment acquisitions on contracts payable and capital leases $ 119 $ 84 $ 813